Enhanced searching using a thesaurus

Details for Australian Patent Application No. 2006274496 (hide)

International Classifications

Event Publications

20 March 2008 PCT application entered the National Phase

PCT publication WO2007/012120 Priority application(s): WO2007/012120

7 July 2011 Application Accepted

Published as AU-B-2006274496

2 February 2012 Standard Patent Sealed

27 September 2012 Application for Amendment

The nature of the amendment is: Amend the name of the inventor to read Redfern, Victoria Lesley . Address for service in Australia - Redfern International Enterprises Pty Ltd G.P.O. Box 2262 Canberra ACT 2617 2006291439 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa The Medicines Company (Leipzig) GmbH The nature of the amendment is: Amend the name of the inventor to read Doennecke, Daniel; Stuerzebecher, Anne; Schweinitz, Andrea; Stuerzebecher, Jorg; S

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.